| Serial Number | 99007634 |
| Word Mark | XTURNPOINT |
| Filing Date | Friday, January 17, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, October 23, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, November 11, 2025 |
| Description of Mark | The mark consists of the stylized wording "XTURNPOINT", with the first letter, an "X", appearing in the colors blue, purple, orange, and green. The white area appearing in the letter is a transparent area and is not being claimed as a feature of the mark. The remainder of the wording, "TURNPOINT", appears in the color black. |
| Goods and Services | Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics |
| Pseudo Mark | X TURN POINT |
| Goods and Services | Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics |
| Goods and Services | Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics |
| Indication of Colors claimed | The color(s) blue, purple, orange, green, and black is/are claimed as a feature of the mark. |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 17, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Xentria, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60631 |
| Event Date | Event Description |
| Friday, January 17, 2025 | NEW APPLICATION ENTERED |
| Sunday, June 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 27, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, July 8, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 8, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, October 8, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 8, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 15, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |